AMGEN PRESENTS NEW LUMAKRAS CODEBREAK 200 CNS DATA AT ASCO 2

THOUSAND OAKS - Amgen today announced the presentation of new data from the CodeBreaK clinical trial program, the most comprehensive global development program in patients with KRAS G12C-mutated... | June 5, 2023

Related Keywords

Houston , Texas , United States , Taiwan , Puerto Rico , Mexico , Brazil , Saudi Arabia , Macao , Macau General , Macau , South Korea , Canada , Russia , Singapore , Japan , Australia , Malaysia , United Arab Emirates , Chicago , Illinois , Tennessee , Thailand , United Kingdom , Turkey , Argentina , Kuwait , Qatar , Colombia , Hong Kong , Israel , Switzerland , American , America , Great Britain , Davidm Reese , Jessica Akopyan , Davids Hong , Melissal Johnson , European Union , Kyowa Kirin Co Ltd , Drug Administration , Teneobio Inc , Sarah Cannon Research Institute At Tennessee Oncology , American Society Of Clinical Oncology , Therapeutics Inc , Beigene Ltd , Exchange Commission , Chemocentryx Inc , Lung Cancer Research , Japan Oncology Group , University Of Texas Md Anderson Cancer Center , Amgen , Clinical Oncology , Annual Meeting , Cancer Research , Cannon Research Institute , Lung Cancer Non Small Cell Metastatic , Consistent Clinical Benefit Across , Investigational Cancer Therapeutics , Cancer Center , Gastrointestinal Cancer Colorectal , Arab Emirates , Non Small Cell Lung Cancer , Advanced Colorectal Cancer , Lung Disease , Dow Jones Industrial Average , Best Employer , Sustainable Companie , Prime Therapeutics , News Publishing , Amgen Inc Stock Exchange , News , Information , Press Release , Thousand , Oaks , Oday , Nnounced , The , Presentation , F , Few , Data , Rom , Odebreak , Linical , Trial , Most , Comprehensive , Lobal , Development , Program , N , Patients , Ith , Ras Amgn Us0311621009 ,